Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis

Pediatric Pulmonology

Volumn 33, Issue 6, 2002, Pages 475-482

  Dakin, Carolyn J ^a,d   Pereira, J K ^b   Henry, Richard L ^c   Wang, He ^c   Morton, John R ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b Medical Department   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

Cystic fibrosis; High resolution computed tomography; Inflammation; Interleukin 8; Pulmonary function; Sputum

Indexed keywords

INTERLEUKIN 8; MARKER;

ADOLESCENT; ADULT; ARTICLE; CELL COUNT; CELL VIABILITY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; IMAGING; LUNG FUNCTION; LUNG FUNCTION TEST; PRIORITY JOURNAL; SCORING SYSTEM; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CELL COUNT; CHILD; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-8; MALE; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 0036107159     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10109     Document Type: Article

References (51)

1. Cystic fibrosis: State of the art
2. High-resolution CT of the lung paremchyma
3. Cystic fibrosis: Scoring system with thin-section CT
4. Ultrafast computerized tomography of the chest in cystic fibrosis: A new scoring system
5. High resolution computed tomography in adult cystic fibrosis patients with mild lung disease
6. Pediatric pulmonary disease: Assessment with high-resolution ultrafast CT
7. Cystic fibrosis: When should high-resolution computed tomography of the chest be obtained?
8. Highresolution CT in the acute exacerbation of cystic fibrosis: Evaluation of acute findings, reversibility of those findings, and clinical correlation
9. High-resolution conputed tomography of the chest in children with cystic fibrosis: Support for use as an outcome surrogate
10. Cystic fibrosis: When should high-resolution computed tomography of the chest be obtained?
11. Cystic fibrosis in children: HRCT findings and distribution of disease
12. High resolution computed tomography in cystic fibrosis: Correlation with pulmonary function and assessment of prognostic value
13. High resolution computed tomography in pulmonary cystic fibrosis
14. Cystic fibrosis: CT assessment of lung involvement in children and adults
15. Serial sputum cell counts in the management of chronic airflow limitation
16. A case for the serial examination of sputum inflammatory cells
17. Usefulness of induced sputum analysis in pulmonary diseases
18. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children
19. Increase in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics
20. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood
21. Assessment of airway inflammation in asthma
22. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects
23. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects
24. Sputum in severe exacerbations of asthma: Kinetics of inflammatory indices after prednisone treatment
25. Assessment of airway inflammation in children with acute asthma using induced sputum
26. Non invasive assessment of bronchial inflammation in asthma: No correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline
27. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects
28. Airway inflammation in COPD assessed by sputum levels of interleukin-8
29. 1 in smokers are associated with increased levels of sputum neutrophils
30. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis
31. Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway disease
32. Modulation of airway inflammation in cytstic fibrosis
33. Cytokines in sputum and serum from patients wth cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs
34. TNF-alpha and immune complexes in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection
35. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilising pilocarpine by iontophoresis
36. ATS statement on standardisation of spirometry - 1994 update
37. Redefining end of test (EOT) criteria for pulmonary function testing in children
38. The maximum expiratory flow volume curve
39. The evaluation of a cell dispersion method of sputum examination
40. Comparison of sputum processing techniques in cystic fibrosis
41. Comparison of two methods of processing induced sputum: Selected versus entire sputum
42. Bronchiectasis: Functional significance of areas of decreased attenuation at expiratory CT
43. Comparison between morphologic changes seen on high-resolution CT and regional pulmonary perfusion seen on SPECT in patients with cystic fibrosis
44. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements
45. Effect of repeated sputum induction on cell counts in normal volunteers
46. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma
47. Induced sputum cellularity
48. Bronchiolitis obliterans: High resolution CT findings and correlation with pulmonary function tests
49. TNFalpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cytstic fibrosis patients
50. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma
51. Lower airway inflammation in infants and young children with cystic fibrosis